Brought to you by

Series A round totals $33mm for Flexion Therapeutics, which adds more later
04 Jun 2012
Executive Summary
Drug development start-up Flexion Therapeutics has completed a $33mm Series A financing led by Versant Ventures, which also took part in the company's $3mm seed round in November 2007. Other founding investors participating in this round were 5AM Ventures and Sofinnova Partners. With a business model based on Lilly Research Lab division Chorus, Flexion hopes to take candidates through proof-of-concept faster and cheaper than the traditional development process. The company expects to soon announce partnerships it has in the works with three as-yet-unannounced pharmacos.
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Financing
- Private Placement
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com